Skip to content

Post-COVID-19: Treatment of long-term consequences of COVID infection (COVID-19)

Post-COVID-19: Treatment of long-term consequences of COVID infection (COVID-19) - Post-COVID-AIB

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00029415
Enrollment
48
Registered
2022-07-04
Start date
2022-06-13
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post COVID

Interventions

Group 1: Participants perform an individualised ambulant therapy program for two weeks. Gait training, balance training, neuropsychology, breathing therapy, medical exercise therapy, and relaxation te

Sponsors

Schön Klinik Bad Aibling
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: COVID-19 infection (proof of a PCR test) = 3 months; COVID symptoms with constraints of the general sense of health; age = 18 years; Access to a mobile phone/ tablet/ computer and experienced in using one of the devices

Exclusion criteria

Exclusion criteria: Indication of a potential life-threatening disease which prohibits participation in the program; current need for an inpatient treatment (acute care or rehabilitation); need for a daily monitoring by nursing staff or the like; cognitive impairment that limit an independent life; insufficient German language skills to participate in the therapy or the study visits; pregnancy; bipolar disorder; severe epilepsy

Design outcomes

Primary

MeasureTime frame
Health-related quality of life (EQ-5D-5L): V1-4; Follow-up 1-2; feasibility of the treatment program: during the intervention period; questionnaires about the patient satisfactions with the program and the app: V3 and Follow-up 1; V1= 2 Weeks before start of the intervention period V2= Beginning of the ambulant intervention period V3= End of the ambulant intervention period V4= 2 weeks after the end of the ambulant intervention period Follow-up 1: 2 months after the end of the intervention period Follow-up 2: 6 months after the end of the intervention period

Secondary

MeasureTime frame
V1-4, Follow-up 1-2: Participation, general disability (Global health and diability), fatigue (Fatigue Severity Scale), frailty (Clinical Frailty Scale), pain, sensibility, mental health (Hospital Anxiety and Depression Scale), cognition (MOCA), endurance (6 Min walking test), balance (mini-BESTest), insomnia, sleep, daytime sleepiness, parameters of the sensors (e.g. gait distance, heart frequency); V3: questionnaire about the therapy program; Follow-up 1: parameters of the app (Motionware 8; intensity of use, therapy minutes.)

Countries

Germany

Contacts

Public ContactMarion Egger

Schön Klinik Bad Aibling

AIBCovidStudie@schoen-klinik.de+4980619031954

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 23, 2026